5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 60.58▼ | 60.54▼ | 60.58▼ | 60.54▼ | 57.49▲ |
MA10 | 60.55▼ | 60.55▼ | 60.44▼ | 59.62▲ | 56.31▲ |
MA20 | 60.28▼ | 59.26▲ | 58.60▲ | 57.77▲ | 58.49▲ |
MA50 | 57.96▲ | 57.08▲ | 57.12▲ | 56.10▲ | 60.97▼ |
MA100 | 58.64▲ | 59.36▲ | 59.63▲ | 58.75▲ | 57.69▲ |
MA200 | 59.05▲ | 58.99▲ | 58.95▲ | 60.85▼ | 52.60▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.123▼ | 0.030▲ | 0.182▲ | 0.362▲ | 0.346▲ |
RSI | 54.025▲ | 57.103▲ | 58.249▲ | 61.137▲ | 52.862▲ |
STOCH | 52.934 | 70.649 | 80.828▲ | 85.021▲ | 65.501 |
WILL %R | -100.000▼ | -50.000 | -30.425 | -21.371▲ | -16.328▲ |
CCI | -151.002▼ | -50.723 | 14.364 | 59.304 | 89.855 |
MA | $BBP Price Crossed Below MA(7) | Set Alert |
Tuesday, April 29, 2025 01:01 PM
Attruby (acoramidis) – First near-complete (≥90%) transthyretin (TTR) stabilizer for treatment of transthyretin amyloid cardiomyopathy (ATTR-CM): FORTIFY is a Phase 3 clinical trial of BBP-418 ...
|
Thursday, April 24, 2025 05:00 PM
US tech stocks led the S&P and Nasdaq higher on Friday after Google parent Alphabet reported strong earnings results and hopes of trade deals grew. - The market expects a widening gap between ...
|
Monday, January 13, 2025 08:10 AM
Jan. 13, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO ... R9 (LGMD2I/R9): FORTIFY is a Phase 3 clinical trial of BBP-418 in LGMD2I/R9, a rare genetic disorder caused by ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 60.36 | 60.36 | 59.95 | 59.9959 | 1,318 |
12/06/25 | 60.46 | 60.5533 | 60.46 | 60.5533 | 429 |
11/06/25 | 61.13 | 61.28 | 60.4324 | 60.4324 | 1,514 |
10/06/25 | 60.87 | 61.24 | 60.87 | 61.24 | 256 |
09/06/25 | 61.29 | 61.29 | 60.33 | 60.471 | 17,889 |
06/06/25 | 59.53 | 60.64 | 59.40 | 60.461 | 5,900 |
05/06/25 | 58.14 | 58.80 | 58.02 | 58.72 | 6,900 |
04/06/25 | 58.61 | 59.09 | 58.5224 | 58.5224 | 1,362 |
03/06/25 | 57.87 | 58.70 | 57.87 | 58.30 | 11,600 |
02/06/25 | 57.52 | 57.76 | 57.50 | 57.50 | 1,716 |
|
|
||||
|
|
||||
|
|